Trial Design Solutions

  1. Rethinking Lab Logistics: Delivering The Complex Without Compromise 9/10/2025

    Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.

  2. Greenphire Patient Payments 10/24/2025

    esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.

  3. Bold Thinking Overcomes Oncology Clinical Development Challenges 5/31/2022

    Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials. 

  4. Rare Disease Center Of Excellence Overcomes Unique Obstacles 7/14/2022

    Biorasi’s Beeline platform provides clinical teams with unique, real-time transparency for quick responses to rare and urgent disease trial challenges.

  5. Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios 5/12/2023

    Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.

  6. Central IRB Services 4/10/2025

    “Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”

    Raffaella Hart, MS, CIP
    Sr. Vice President, IRB and IBC Services

    Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.

  7. Clinical And Regulatory Strategy 11/7/2023

    Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.

  8. Medical Writing: A Collaborative Approach 7/31/2024

    Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.

  9. Human Abuse Potential 4/17/2024

    With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

  10. Going The Extra Mile To Enhance Every Patient's Experience 10/11/2023

    Delve into the details of our Patient Navigator services, which are designed to eliminate patients’ barriers to clinical trial participation and maximize study outcomes through patient experience.